Back to the list
Congress: ECR25
Poster Number: C-11697
Type: Poster: EPOS Radiologist (scientific)
DOI: 10.26044/ecr2025/C-11697
Authorblock: A. Smirnova, E. V. Kondratyev; Moscow/RU
Disclosures:
Aleksandra Smirnova: Author: radiologist, postgraduate student of the Department of Radiation Diagnostic Methods, A. V. Vishnevsky National Medical Research Center of Surgery, Moscow, Russian Federation ORCID: https://orcid.org/0000-0002-5470-0999
Evgeny V Kondratyev: Author: Cand. Sci. (Medicine), Senior Researcher, Department of Radiation Diagnostic Methods, A. V. Vishnevsky National Medical Research Center of Surgery, Moscow, Russian Federation ORCID: https://orcid.org/0000-0001-7070-3391, SPIN: 2702-6526, Author ID: 243610, Scopus Author ID: 55865664400, Web of Science ResearcherID: ABD-5758-2020
Keywords: Abdomen, Oncology, CT, MR-Cholangiography, Computer Applications-General, Cancer
References
  1. Gurmikov BN, Kovalenko YuA, Vishnevsky VA, Chzhao AV. Molecular genetic aspects of intrahepatic cholangiocarcinoma: literature review. Advances in Molecular Oncology. 2019;6(1):37–43. (In Russ.). https://doi.org/10.17650/2313-805x-2019-6-1-37-432. Karmazanovsky GG. The role of MDCT and MRI in the diagnosis of focal liver diseases. Annals of HPB Surgery. 2019;24(4):91–110.(In Russ.). https://doi.org/10.16931/1995-5464.2019491-1103. Baheti AD, Thirumani SH, Sinagare AB, Rosenthal MH, Hornik JL, Ramaiah NH, Wolpin BM. Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at presentation with metastatic spread and clinical outcomes: a retrospective study of 92 patients. Abdominalimaging. 2014; 39(6):1193–1201. https://doi.org/10.1007/s00261-014-0167-04. Fujita N, Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, et al. Mass-forming intrahepatic cholangiocarcinoma: En-hancement patterns in the arterial phase of dynamic hepatic CT – Correlation with clinicopathological findings. Eur Radiol.2017 Feb;27(2):498–506. https://doi.org/10.1007/s00330-016-4386-35. Xu X, Mao Y, Tang Y, Liu Y, Xue C, Yue Q, et al. Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Radiomic Analysis. Comput Math Methods Med. 2022 Feb 21;2022:5334095. https://doi.org/10.1155/2022/53340956. Aherne EA, Pak LM, Goldman DA, Gonen M, Jarnagin WR, Simpson AL, Do RK. Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics? Abdom Radiol (NY). 2018 Oct;43(10):2665–2672.https://doi.org/10.1007/s00261-018-1505-47. Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009 May-Jun;29(3):683–700. https://doi.org/10.1148/rg.2930857298. Popov EV, Krivonogov NG, Okrugin SA, Sazonova SI. Radiomic image analysis in cardiology: possibilities and prospects of application: a review. Diagnostic radiology and radiotherapy. 2022;2(13):7–15. (In Russ.).https://doi.org/10.22328/2079-5343-2022-13-2-7-159. Mar WA, Shon AM, Lu Y, Yu JH, Berggruen SM, Guzman G, et al. Imaging spectrum of cholangiocarcinoma: role in diagnosis, staging, and posttreatment evaluation. Abdom Radiol (NY). 2016 Mar;41(3):553–567. https://doi.org/10.1007/s00261-015-0583-910. Robertson S, Hyder O, Dodson R, Nayar SK, Poling J, Beierl K, et al. The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome. Hum Pathol. 2013 Dec;44(12):2768–2773.https://doi.org/10.1016/j.humpath.2013.07.02611. Yang L, Dong D, Fang M, Zhu Y, Zang Y, Liu Z, et al. Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer? EurRadiol. 2018 May;28(5):2058–2067. https://doi.org/10.1007/s00330-017-5146-812. Borger DR, Tanabe KK, Fan KC, Lopez HU, Fantin VR, Straley KS, et al. Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist. 2012;17(1):72–79.https://doi.org/10.1634/theoncologist.2011-038613. Kim SA, Lee JM, Lee KB, Kim SH, Yoon SH, Han JK, Choi BI. Intrahepatic mass-forming cholangiocarcinomas: enhancement patternsat multiphasic CT, with special emphasis on arterial enhancement pattern – correlation with clinicopathologic findings. Radiology.2011 Jul;260(1):148–157. https://doi.org/10.1148/radiol.1110177714. Liu N, Wu Y, Tao Y, Zheng J, Huang X, Yang L, Zhang X. Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics. Cancers (Basel). 2023 Nov 11;15(22):5373. https://doi.org/10.3390/cancers1522537315. Wang X, Wang S, Yin X, Zheng Y. MRI-based radiomics distinguish different pathological types of hepatocellular carcinoma. Comput Biol Med. 2022 Feb;141:105058. https://doi.org/10.1016/j.compbiomed.2021.10505816. Taouli B, Hoshida Y, Kakite S, Chen X, Tan PS, Sun X, et al. Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results. Eur Radiol. 2017 Nov;27(11):4472–4481.https://doi.org/10.1007/s00330-017-48446

    2.  
GALLERY